Roughly 26 million Americans have diabetes and the number is expected to soar in the coming years, reaching nearly half of all Americans by 2020. Diabetes is responsible for $116 billion in direct medical costs annually. Hospitals and health systems will be challenged in the coming years to improve health for this population.
This two-day conference on Diabetes Centers of Excellence for Hospitals and Health Systems will examine the impact the diabetes epidemic is having on the delivery system and how hospitals are responding.
The already alarming still growing wave of diabetes cases is crashing into a health care delivery system that was not designed to handle chronic disease. The epidemic will test whether the health care field can transform itself to meet the demands of the disease and the Affordable Care Act.
About 26 million Americans have diabetes – 19 million diagnosed and 7 million undiagnosed, according to the National Institutes of Health. Estimates show that by 2050 between 1 in 3 and 1 in 5 Americans will have the disease. Reasons for the spike include the aging population, growth of the populations at high-risk of type 2 diabetes, and people with diabetes who are living longer. At the same time that the number of diabetics is increasing, health reform will do away with the barriers that blocked their access to care.
This conference features a site tour of Joslin Diabetes Center, located in Boston, Massachusetts, the world’s largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.
This conference is designed for Senior Level Executives, Vice Presidents, Administrators, Directors and Managers within hospitals, health systems, federal and state agencies, as well as healthcare consultants. Academic Medical Centers, Teaching Hospitals, and Community Hospitals are also encouraged to attend.
We at the Diabetes Hands Foundation believe no one touched by diabetes should ever feel alone, because together we become stronger and have the power to generate positive change in ourselves and our community. Diabetes can be a very isolating disease, so we provide platforms where people with diabetes and their loved ones can connect and have an open dialog about their experiences with this chronic condition. Instead of looking at the disease, Diabetes Hands Foundation seeks to understand, connect and energize the millions of people living with this condition.
DiabetesSisters was founded in January 2008 by a woman who was diagnosed with diabetes as a teenager in the early 1990s. In addition to being faced with many obstacles, including social isolation, she was amazed how little information about or services for women with diabetes were available and how the issue seemed invisible within the women’s health community. Her high-risk pregnancy further illuminated the limited number of resources available to women with diabetes during important life stages, such as puberty, pregnancy, and menopause. All of her experiences culminated in the formation of DiabetesSisters in January 2008.
The Lancet publishes a weekly journal and six monthly specialty journals in the fields of global health, diabetes and endocrinology, oncology, neurology, respiratory medicine, and infectious diseases. All Lancet journals are published online and in print, with the exception of The Lancet Global Health, which is exclusively online. The Lancet Oncology’s Review, Commentary, and Breaking News sections are published exclusively online.
Medical Daily strives to provide timely, coherent, and accurately sourced information about breaking health news, scientific trends, and innovations. Our mission is to contribute to our readers’ personal health empowerment by helping make sense of the complex and constantly changing field of medical knowledge. We intend to deliver news you can use about the latest developments in medicine, with thorough analysis and no ambiguity about its validity or accuracy. We value honesty, balance, and credibility in our reporting, and aim to present all developments in scientific research clearly, succinctly, factually, and in context, with interpretations that include diverse perspectives and expert commentary.
PharmaVOICE.com is a Website for life-sciences executives and other healthcare-service related professionals. PharmaVOICE.com is produced by PharmaLinx LLC, publishers of PharmaVOICE magazine and the VIEWs. The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVOICE.com has readers from around the world. PharmaVOICE.com provides access to all of the articles that have appeared in the print publications of PharmaVOICE and the VIEWs. PharmaVOICE.com also provides an online calendar of industry events, an online discussion forum, a monthly interactive opinion poll, and other online content, supported by a robust search engine.
Xconomy is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. We are the authoritative voice on the exponential economy, the realm of business and innovation characterized by exponential technological growth and responsible for an increasing share of productivity and overall economic growth. We deliver this valuable content through a unique global network of localized blogs, events, conferences, and other initiatives designed to better connect people and ideas.